×
About 19,077 results

ALLMedicine™ Diabetic Nephropathy Center

Research & Reviews  8,825 results

An insight on safety, efficacy, and molecular docking study reports of N-acetylcysteine...
https://doi.org/10.1515/jbcpp-2020-0099
Journal of Basic and Clinical Physiology and Pharmacology; Rind L, Ahmad M et. al.

Feb 27th, 2021 - N-acetylcysteine (NAC) is considered as the body's major antioxidant molecules with diverse biological properties. In this review, the pharmacokinetics, safety and efficacy report on both the preclinical and clinical summary of NAC is discussed. B...

CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys.
https://doi.org/10.1016/j.taap.2021.115465
Toxicology and Applied Pharmacology; Yang X, Luo W et. al.

Feb 25th, 2021 - Diabetic nephropathy (DN) is a chronic inflammatory renal disease induced by hyperglycemia. Recent studies have implicated cyclin-dependent kinase 9 (CDK9) in inflammatory responses and renal fibrosis. In this study, we explored a potential role o...

An updated pharmacological insight of resveratrol in the treatment of diabetic nephropa...
https://doi.org/10.1016/j.gene.2021.145532
Gene Li KX, Ji MJ et. al.

Feb 25th, 2021 - As one of the most common complications of diabetes, nephropathy develops in approximately 40% of diabetic individuals. Although end stage kidney disease is known as one of the most consequences of diabetic nephropathy, the majority of diabetic in...

Nephroprotective Effect of Adropinin Against Streptozotocin-Induced Diabetic Nephropath...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896734
Drug Design, Development and Therapy; Guo L, Jiang B et. al.

Feb 24th, 2021 - Diabetic Nephropathy remains a major cause of morbidity and mortality in patients suffering from renal dysfunction. This study accessed the nephroprotective role of Adropinin against streptozotocin (STZ) induced diabetic nephropathy in rats and sc...

see more →

Guidelines  2 results

Validation of the 2007 kidney disease outcomes quality initiative clinical practice gui...
https://doi.org/10.1016/j.diabres.2018.11.008
Diabetes Research and Clinical Practice; Liu XM, Dong ZY et. al.

Nov 25th, 2018 - Diabetes mellitus (DM) has overtaken infection and immunological factors as the most common cause of end-stage renal disease. The 2007 Kidney Disease Outcomes Quality Initiative (KDOQI) guideline is a widely accepted guideline for the clinical dia...

Management of adults with diabetes on the haemodialysis unit: summary of guidance from ...
https://doi.org/10.1111/dme.13676
Diabetic Medicine : a Journal of the British Diabetic Ass... Frankel AH, Kazempour-Ardebili S et. al.

Aug 28th, 2018 - Diabetic nephropathy remains the principal cause of end-stage renal failure in the UK and its prevalence is set to increase. People with diabetes and end-stage renal failure on maintenance haemodialysis are highly vulnerable, with complex comorbid...

see more →

Drugs  551 results see all →

Clinicaltrials.gov  9,513 results

An insight on safety, efficacy, and molecular docking study reports of N-acetylcysteine...
https://doi.org/10.1515/jbcpp-2020-0099
Journal of Basic and Clinical Physiology and Pharmacology; Rind L, Ahmad M et. al.

Feb 27th, 2021 - N-acetylcysteine (NAC) is considered as the body's major antioxidant molecules with diverse biological properties. In this review, the pharmacokinetics, safety and efficacy report on both the preclinical and clinical summary of NAC is discussed. B...

CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys.
https://doi.org/10.1016/j.taap.2021.115465
Toxicology and Applied Pharmacology; Yang X, Luo W et. al.

Feb 25th, 2021 - Diabetic nephropathy (DN) is a chronic inflammatory renal disease induced by hyperglycemia. Recent studies have implicated cyclin-dependent kinase 9 (CDK9) in inflammatory responses and renal fibrosis. In this study, we explored a potential role o...

An updated pharmacological insight of resveratrol in the treatment of diabetic nephropa...
https://doi.org/10.1016/j.gene.2021.145532
Gene Li KX, Ji MJ et. al.

Feb 25th, 2021 - As one of the most common complications of diabetes, nephropathy develops in approximately 40% of diabetic individuals. Although end stage kidney disease is known as one of the most consequences of diabetic nephropathy, the majority of diabetic in...

Nephroprotective Effect of Adropinin Against Streptozotocin-Induced Diabetic Nephropath...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896734
Drug Design, Development and Therapy; Guo L, Jiang B et. al.

Feb 24th, 2021 - Diabetic Nephropathy remains a major cause of morbidity and mortality in patients suffering from renal dysfunction. This study accessed the nephroprotective role of Adropinin against streptozotocin (STZ) induced diabetic nephropathy in rats and sc...

see more →

News  177 results

CKD: Dapagliflozin Offers Benefits Regardless of Diabetes Status
https://www.medscape.com/viewarticle/944379

Jan 21st, 2021 - Takeaway Dapagliflozin lowers the risks of major adverse kidney and cardiovascular (CV) events and all-cause mortality in patients with chronic kidney disease (CKD), regardless of type 2 diabetes (T2D) status. These benefits also extend to patient...

Is the Kidney Merely a 'Bystander' When it Comes to COVID-19?
https://www.staging.medscape.com/viewarticle/935505

Aug 10th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new Canadian study has found increased expression of angiotensin-converting enzyme 2 (ACE2) receptors in the kidneys of patients with diabetic n...

Is the Kidney Merely a 'Bystander' When it Comes to COVID-19?
https://www.medscape.com/viewarticle/935505

Aug 10th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new Canadian study has found increased expression of angiotensin-converting enzyme 2 (ACE2) receptors in the kidneys of patients with diabetic n...

Fast Five Quiz: Diabetic Nephropathy
https://reference.medscape.com/viewarticle/926147_3

Apr 23rd, 2020 - Answer 2/5 Which of the following statements about diabetic nephropathy is accurate? Your peers chose: The rate of diabetic nephropathy progressively increases in individuals who have had diabetes for more than 20 years 0% Diabetic nephropathy fre...

Fast Five Quiz: Diabetic Nephropathy Management
https://reference.medscape.com/viewarticle/926149_1

Apr 23rd, 2020 - Diabetes is a growing global public health epidemic. According to data from the International Diabetes Federation, there were more than 450 million individuals worldwide with diabetes in 2017; by 2045, that number is expected to increase to 693 mi...

see more →

Patient Education  9 results see all →